# ‚≠ê [Tier A] Alzheimer's Disease Neuroimaging Dataset

**Paper**: https://www.semanticscholar.org/paper/fce6c72cd2b3ac7e726b6ca105c782cbb8f44c71
**Published**: 2025-06-15
**Citations**: 3
**Source**: semantic_scholar

---

## üí∞ Business Opportunity

Alzheimer's disease is a major health challenge with a significant unmet need for early detection and intervention. A high-quality dataset of neuroimaging data could enable the development of advanced AI-based diagnostic tools, which would be valuable for healthcare providers, pharmaceutical companies, and medical research institutions.

**Target Customers**: Healthcare providers, pharmaceutical companies, medical research institutions, and AI/ML solution providers focused on Alzheimer's disease and neurological disorders.
**Market Gap**: Current neuroimaging datasets for Alzheimer's research are often limited in size, diversity, or accessibility. A new, comprehensive dataset could help accelerate the development of novel AI-powered solutions for early Alzheimer's detection.

---

## üìä Scoring

**Value Score**: 7.5/10
**Confidence**: 8.0/10
**Tier**: A

**Enhanced Dimensions**:
- Data Efficiency: 8.0/10
- Source Quality: 7.0/10
- Generalizability: 7.0/10

**Signals Detected**:


---
## ‚ö†Ô∏è Concerns

Collecting and curating a high-quality neuroimaging dataset for Alzheimer's research may require significant time, resources, and collaboration with medical experts. Ensuring patient privacy and data security will also be critical.

---

*Detected: 2025-11-13 23:10:57 UTC*
*Finding ID: rdla_20251113_231057*
